NORDITROPIN 5 MG

国家: 以色列

语言: 英文

来源: Ministry of Health

现在购买

公众评估报告 公众评估报告 (PAR)
18-08-2016

有效成分:

SOMATROPIN

可用日期:

NOVO NORDISK LTD., ISRAEL

ATC代码:

H01AC01

药物剂型:

SOLUTION FOR INJECTION

组成:

SOMATROPIN 3.3 MG / 1 ML

给药途径:

S.C

处方类型:

Required

厂商:

NOVO NORDISK A/S, DENMARK

治疗组:

SOMATROPIN

治疗领域:

SOMATROPIN

疗效迹象:

Children: Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome. Short stature in children with renal insufficiency. Growth disturbance (current height SDS < - 2.5 and parental adjusted height SDS < - 1) in short children born small for gestational age (SGA) with a birth weight and/or length below - 2 SD who failed to show catch-up growth (HV SDS < during the last year) by 4 years of age or later.Children with short stature associated with Noonan syndrome.Adults: Treatment of adults with Hypothalamic-pituitary disease resulting from organic disease or pituitary tumors treated medically surgically or radiotherapy or patients with chilhood onset of G.H. deficiency. תוספת התוויה: 5/6/2019Indication:Children: Short stature due to inadequate or failed secretion of pituitary growth hormone or Turner`s syndrome.Short stature in children with renal insufficiency.Growth disturbance (current height SDS < -2.5 and parental adjusted height SDS < -1) in short childre

授权日期:

2020-05-31

搜索与此产品相关的警报